Evidence map›Paper›PMID 34465290›Full record

ArticleBMC pediatrics2021

Neonatal rebound hyperkalemia associated with ritodrine alone: a case report.

Keita Osumi, Kenichi Suga, Masashi Suzue, Ryuji Nakagawa, Shoji Kagami

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Keita OsumiDepartment of Pediatrics, Tokushima University Hospital, 2-50-1 Kuramotocho, Tokushima, 770-8503, Japan.
Kenichi SugaDepartment of Pediatrics, Tokushima University Hospital, 2-50-1 Kuramotocho, Tokushima, 770-8503, Japan. suga.kenichi.1@tokushima-u.ac.jp.ORCID 0000-0003-3588-4347
Masashi SuzueDepartment of Pediatrics, Tokushima University Hospital, 2-50-1 Kuramotocho, Tokushima, 770-8503, Japan.
Ryuji NakagawaDepartment of Pediatrics, Tokushima University Hospital, 2-50-1 Kuramotocho, Tokushima, 770-8503, Japan.
Shoji KagamiDepartment of Pediatrics, Tokushima University Hospital, 2-50-1 Kuramotocho, Tokushima, 770-8503, Japan.
Tokushima University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBetamimetics have been used for tocolysis extensively in the past, and one of them, ritodrine is widely used in Japan. Various adverse events have been reported for this agent, including newborn hypoglycemia and hypokalemia, as well as maternal hypokalemia and rebound hyperkalemia; however, cases of neonatal rebound hyperkalemia are not described in the literature. CASE PRESENTATION: A male infant born at 36 weeks of gestation by cesarean section at a local maternity clinic suddenly entered cardiopulmonary arrest with ventricular tachycardia and fibrillation due to hyperkalemia (K

conclusionsThis case report serves as a warning regarding the potential risk of neonatal rebound hyperkalemia in association with maternal long-term ritodrine administration.

Indexed as

HyperkalemiaObstetric Labor, PrematureRitodrineTocolytic AgentsCesarean SectionFemaleHumansInfantInfant, NewbornMalePregnancyRitodrineTocolytic AgentsBetamimeticInsulinNeonatal hyperkalemiaPretermRitodrineTocolysis

Identifiers

PMID34465290
PMCPMC8405715
OpenAlexW3198418653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.